Retinalamin: The Peptide for Tissue That Cannot Be Replaced
A peptide extract for the retina — nerve tissue that, once lost, the body has no way of rebuilding.
What Is Retinalamin?
Retinalamin is a peptide extract taken from retinal tissue, and one of the six peptide preparations from the Khavinson programme introduced into Soviet medical practice. It is registered in Russia for ophthalmic use.
Why the retina is a special case, in plain language: the retina is not really part of the eye in the way a lens is. It is brain tissue that happens to sit at the back of the eyeball — an outpost of the central nervous system, pushed forward during development to meet the light. And it inherits the central nervous system’s worst property: when those cells die, they are not replaced. A cut on your arm heals. A lost retinal neuron is simply gone. That is why research on retinal tissue is overwhelmingly about protecting what is there rather than regrowing what is not.
What the Research Examines
Retinalamin is registered in Russia for conditions including diabetic retinopathy, glaucoma-related optic nerve damage and retinal dystrophy. That registration is genuine and applies to a specific pharmaceutical product in that country — it does not extend to the TGA, FDA or EMA.
As a first-generation extract it is a mixture of peptides rather than a single defined molecule, with the same consequence as Thymalin or Cortexin: a stated purity figure cannot mean what it means for a synthesised peptide. The supporting literature is largely Russian-language and originates chiefly from within that research and regulatory tradition.
Nerve Tissue With No Replacement
The retina is not really part of the eye in the way the lens or cornea are. Developmentally it is an outgrowth of the brain — nerve tissue that migrated forward during development and stayed there.
That matters because it inherits the brain's central limitation. Retinal nerve cells, once lost, are not replaced. The cornea heals from scratches within days. The retina does not heal at all in that sense; damage to it is permanent.
Picture the difference between a windscreen and the driver behind it. A chipped windscreen can be repaired or swapped. Nothing about the driver works that way. Most eye problems are windscreen problems; retinal problems are not.
The tissue is also extraordinarily demanding. Per gram, the retina consumes more oxygen than almost any tissue in the body — running a continuous, high-speed conversion of light into electrical signal. High energy demand and no capacity for replacement is an unforgiving combination, and it is precisely why maintenance rather than repair is the only available framing.
Frequently Asked Questions
Compiled by the Southern Pacific Labs research team. Last updated July 2026.
Published References
- Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
- Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
- Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
- Fedoreyeva LI, Kireev II, Khavinson VKh, et al. “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.” Biochemistry. Biokhimiia, 2011. PubMed
Related Research Guides
More in Bioregulators & Neuropeptides
The whole Khavinson system — one peptide per organ, and the honest state of the evidence.
Read guide →Brain Peptide ExtractThe other neurological extract from the same programme.
Read guide →Thymic Peptide ExtractThe thymus extract, and the same extract-versus-synthetic distinction.
Read guide →